Genotypic Resistance Testing

Selection of the HIV-1 Reverse Transcriptase Mutation K70E in Antiretroviral-Naïve Subjects Treated with Tenofovir/Abacavir/Lamivudine Therapy 6-17-05

Properties of In Vitro Generated HIV-1 Variants Resistant to the CCR5 Antagonists  SCH 351125 and SCH 417690 6-17-05

Reduced Susceptibility to Protease Inhibitors (PI) in the Absence of Primary PI Resistance-Associated Mutations 6-15-05

Return to Conference Main Page